ZIOPHARM Oncology, Inc. Selected To Join Russell 3000(R)

NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced that it has been selected for inclusion in the Russell Microcap®, 3000®, and Global® Indexes, effective immediately. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. Inclusion confers eligibility for a number of growth and value stock indexes and corresponding funds. Russell criteria for membership in its equity indexes is based primarily on market capitalization and style attributes.
MORE ON THIS TOPIC